|
1
|
Wu M, Fan Y, Lv S, Xiao B, Ye M and Zhu X:
Vincristine and temozolomide combined chemotherapy for the
treatment of glioma: A comparison of solid lipid nanoparticles and
nanostructured lipid carriers for dual drugs delivery. Drug Deliv.
23:2720–2725. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Alves TR, Lima FR, Kahn SA, Lobo D, Dubois
LG, Soletti R, Borges H and Neto VM: Glioblastoma cells: A
heterogeneous and fatal tumor interacting with the parenchyma. Life
Sci. 89:532–539. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Castro MG, Candolfi M, Kroeger K, King GD,
Curtin JF, Yagiz K, Mineharu Y, Assi H, Wibowo M, Muhammad Ghulam
AK, et al: Gene therapy and targeted toxins for glioma. Curr Gene
Ther. 11:155–180. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Xiao B, Zhou X, Ye M, Lv S, Wu M, Liao C,
Han L, Kang C and Zhu X: MicroRNA-566 modulates vascular
endothelial growth factor by targeting Von Hippel-Landau in human
glioblastoma in vitro and in vivo. Mol Med Rep.
13:379–385. 2016.PubMed/NCBI
|
|
5
|
Fan YH, Ye MH, Wu L, Lv SG, Wu MJ, Xiao B,
Liao CC, Ji QK, Chai Y and Zhu XG: Overexpression of miR-98
inhibits cell invasion in glioma cell lines via downregulation of
IKKε. Eur Rev Med Pharmacol Sci. 19:3593–3604. 2015.PubMed/NCBI
|
|
6
|
Wu L, Yang L, Xiong Y, Guo H, Shen X,
Cheng Z, Zhang Y, Gao Z and Zhu X: Annexin A5 promotes invasion and
chemoresistance to temozolomide in glioblastoma multiforme cells.
Tumour Biol. 35:12327–12337. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kitagawa H, Izumikawa T, Uyama T and
Sugahara K: Molecular cloning of a chondroitin polymerizing factor
that cooperates with chondroitin synthase for chondroitin
polymerization. J Biol Chem. 278:23666–23671. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kalathas D, Theocharis DA, Bounias D,
Kyriakopoulou D, Papageorgakopoulou N, Stavropoulos MS and Vynios
DH: Alterations of glycosaminoglycan disaccharide content and
composition in colorectal cancer: Structural and expressional
studies. Oncol Rep. 22:369–375. 2009.PubMed/NCBI
|
|
9
|
Pothacharoen P, Siriaunkgul S, Ong-Chai S,
Supabandhu J, Kumja P, Wanaphirak C, Sugahara K, Hardingham T and
Kongtawelert P: Raised serum chondroitin sulfate epitope level in
ovarian epithelial cancer. J Biochem. 140:517–524. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kalathas D, Theocharis DA, Bounias D,
Kyriakopoulou D, Papageorgakopoulou N, Stavropoulos MS and Vynios
DH: Chondroitin synthases I, II, III and chondroitin sulfate
glucuronyltransferase expression in colorectal cancer. Mol Med Rep.
4:363–368. 2011.PubMed/NCBI
|
|
11
|
Ogawa H, Shionyu M, Sugiura N, Hatano S,
Nagai N, Kubota Y, Nishiwaki K, Sato T, Gotoh M, Narimatsu H, et
al: Chondroitin sulfate synthase-2/chondroitin polymerizing factor
has two variants with distinct function. J Biol Chem.
285:34155–34167. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu H, Liang S, Yang X, Ji Z, Zhao W, Ye X
and Rui J: RNAi-mediated RPL34 knockdown suppresses the growth of
human gastric cancer cells. Oncol Rep. 34:2267–2272.
2015.PubMed/NCBI
|
|
13
|
Ivo D'Urso P, Fernando D'Urso O, Damiano
Gianfreda C, Mezzolla V, Storelli C and Marsigliante S: miR-15b and
miR-21 as circulating biomarkers for diagnosis of glioma. Curr
Genomics. 16:304–311. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Viswanath P and Ronen SM: Metabolic
reprogramming of pyruvate dehydrogenase is essential for the
proliferation of glioma cells expressing mutant IDH1. Mol Cell
Oncol. 3:e10779222016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Prinz RD, Willis CM, van Kuppevelt TH and
Klüppel M: Biphasic role of chondroitin sulfate in cardiac
differentiation of embryonic stem cells through inhibition of
Wnt/β-catenin signaling. PLoS One. 9:e923812014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Willis CM and Klüppel M: Chondroitin
sulfate-E is a negative regulator of a pro-tumorigenic
Wnt/beta-catenin-Collagen 1 axis in breast cancer cells. PLoS One.
9:e1039662014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Klüppel M: The roles of
chondroitin-4-sulfotransferase-1 in development and disease. Prog
Mol Biol Transl Sci. 93:113–132. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Karangelis DE, Kanakis I, Asimakopoulou
AP, Karousou E, Passi A, Theocharis AD, Triposkiadis F, Tsilimingas
NB and Karamanos NK: Glycosaminoglycans as key molecules in
atherosclerosis: The role of versican and hyaluronan. Curr Med
Chem. 17:4018–4026. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fthenou E, Zong F, Zafiropoulos A, Dobra
K, Hjerpe A and Tzanakakis GN: Chondroitin sulfate A regulates
fibrosarcoma cell adhesion, motility and migration through JNK and
tyrosine kinase signaling pathways. In Vivo. 23:69–76.
2009.PubMed/NCBI
|
|
20
|
Denholm EM, Lin YQ and Silver PJ:
Anti-tumor activities of chondroitinase AC and chondroitinase B:
Inhibition of angiogenesis, proliferation and invasion. Eur J
Pharmacol. 416:213–221. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Teh MT, Gemenetzidis E, Patel D, Tariq R,
Nadir A, Bahta AW, Waseem A and Hutchison IL: FOXM1 induces a
global methylation signature that mimics the cancer epigenome in
head and neck squamous cell carcinoma. PLoS One. 7:e343292012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kalathas D, Triantaphyllidou IE,
Mastronikolis NS, Goumas PD, Papadas TA, Tsiropoulos G and Vynios
DH: The chondroitin/dermatan sulfate synthesizing and modifying
enzymes in laryngeal cancer: Expressional and epigenetic studies.
Head Neck Oncol. 2:272010. View Article : Google Scholar : PubMed/NCBI
|
